HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $206 | -6.4% | 48 | +20.0% | 0.00% | – |
Q2 2023 | $220 | -78.0% | 40 | -89.1% | 0.00% | – |
Q2 2022 | $1,000 | -87.5% | 367 | -73.3% | 0.00% | – |
Q1 2022 | $8,000 | +166.7% | 1,375 | +249.9% | 0.00% | – |
Q4 2021 | $3,000 | -99.1% | 393 | -99.6% | 0.00% | – |
Q1 2016 | $324,000 | -2.4% | 107,384 | +12.1% | 0.00% | – |
Q4 2015 | $332,000 | -8.3% | 95,784 | 0.0% | 0.00% | – |
Q3 2015 | $362,000 | -88.6% | 95,784 | -82.8% | 0.00% | – |
Q2 2015 | $3,169,000 | +461.9% | 556,018 | +473.9% | 0.00% | – |
Q1 2015 | $564,000 | +2.7% | 96,884 | 0.0% | 0.00% | – |
Q4 2014 | $549,000 | -92.3% | 96,884 | -93.6% | 0.00% | -100.0% |
Q2 2013 | $7,131,000 | – | 1,507,612 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |